Literature DB >> 17693102

Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity.

Pauline Lee1, Jill Waalen, Karen Crain, Aaron Smargon, Ernest Beutler.   

Abstract

A common polymorphism in the chitotriosidase gene (CHIT1) exists in which a 24 bp duplication in exon 10 results in aberrant splicing and deletion of 87 nucleotides. In this study, the gene frequency was found to be 0.56 (n=2054) in subjects of Asian ancestry, 0.17 (n=984) in subjects of European ancestry and 0.07 (n=536) in subjects of African ancestry. Notably, the median enzyme activity in wild-type subjects (TT) was much higher in subjects of European ancestry (2.69 mU/ml, n=202 subjects), than subjects of African (2.57 mU/ml, n=230 subjects) (P<0.0001) and Asian ancestry (0.86 mU/ml, n=114 subjects) (P<0.0001). The question of why chitotriosidase deficiency exists at such a high frequency is a challenging one. We postulated that if there was a selective advantage for chitotriosidase deficiency then there would be polymorphisms that would be associated with reduced enzyme activity independent of the 24 bp duplication. We found that the G102S and the A442G polymorphisms found occurring in subjects of all ancestries were not significantly associated with a reduction of enzyme activity. In contrast, the G354R (P<0.0001) and the A442V (P=0.0013) polymorphisms occurring predominantly in subjects of African ancestry were significantly associated with reduced chitotriosidase activity. We also investigated the possibility that chitotriosidase deficiency was associated with tuberculosis or with atopy, including allergic rhinitis, contact dermatitis, food or drug allergies and asthma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693102      PMCID: PMC2696477          DOI: 10.1016/j.bcmd.2007.06.013

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  32 in total

1.  Plasma chitotriosidase activity in patients with beta-thalassemia.

Authors:  R Barone; F Di Gregorio; M A Romeo; G Schilirò; L Pavone
Journal:  Blood Cells Mol Dis       Date:  1999-02       Impact factor: 3.039

2.  Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patients.

Authors:  Eun Hwa Choi; James G Taylor; Charles B Foster; Thomas J Walsh; Veli-Jukka Anttila; Tapani Ruutu; Aarno Palotie; Stephen J Chanock
Journal:  Med Mycol       Date:  2005-06       Impact factor: 4.076

3.  Plasma chitotriosidase activity and malaria.

Authors:  Y-H Chien; J-H Chen; W-L Hwu
Journal:  Clin Chim Acta       Date:  2005-03       Impact factor: 3.786

4.  Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma.

Authors:  Y Shibata; L A Foster; M Kurimoto; H Okamura; R M Nakamura; K Kawajiri; J P Justice; M R Van Scott; Q N Myrvik; W J Metzger
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

Review 5.  Gaucher disease: new molecular approaches to diagnosis and treatment.

Authors:  E Beutler
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

6.  Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages.

Authors:  L Malaguarnera; M Musumeci; M Di Rosa; A Scuto; S Musumeci
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

7.  Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages.

Authors:  R G Boot; T A van Achterberg; B E van Aken; G H Renkema; M J Jacobs; J M Aerts; C J de Vries
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

8.  Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia.

Authors:  T Lehrnbecher; T Bernig; M Hanisch; U Koehl; M Behl; D Reinhardt; U Creutzig; T Klingebiel; S J Chanock; D Schwabe
Journal:  Leukemia       Date:  2005-10       Impact factor: 11.528

9.  The human chitotriosidase gene. Nature of inherited enzyme deficiency.

Authors:  R G Boot; G H Renkema; M Verhoek; A Strijland; J Bliek; T M de Meulemeester; M M Mannens; J M Aerts
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

10.  Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.

Authors:  C E Hollak; S van Weely; M H van Oers; J M Aerts
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  17 in total

1.  Biochemical and Molecular Chitotriosidase Profiles in Patients with Gaucher Disease Type 1 in Minas Gerais, Brazil: New Mutation in CHIT1 Gene.

Authors:  Talita E R Adelino; Gustavo G Martins; Aretta A A Gomes; Adriana A Torres; Daniel A S Silva; Vinícius D O Xavier; João Paulo O Guimarães; Sérgio S S Araújo; Rachel A F Fernandes; Maria Christina L A Oliveira; Ana Lúcia B Godard; Eugênia R Valadares
Journal:  JIMD Rep       Date:  2012-10-13

2.  Chitotriosidase deficiency: a mutation update in an african population.

Authors:  Silke Arndt; Angela Hobbs; Iain Sinclaire; Anthony B Lane
Journal:  JIMD Rep       Date:  2012-12-29

3.  Allele frequency of a 24 bp duplication in exon 10 of the CHIT1 gene in the general Korean population and in Korean patients with Gaucher disease.

Authors:  Kyu Ha Woo; Beom Hee Lee; Sun Hee Heo; Jae-Min Kim; Gu-Hwan Kim; Yoo-Mi Kim; Ja Hye Kim; In-Hee Choi; Song Hyun Yang; Han-Wook Yoo
Journal:  J Hum Genet       Date:  2014-03-13       Impact factor: 3.172

4.  Treatment with rhDNase in patients with cystic fibrosis alters in-vitro CHIT-1 activity of isolated leucocytes.

Authors:  M Weckmann; C Schultheiss; A Hollaender; I Bobis; J Rupp; M V Kopp
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

Review 5.  Chitinase from Thermomyces lanuginosus SSBP and its biotechnological applications.

Authors:  Faez Iqbal Khan; Krishna Bisetty; Suren Singh; Kugen Permaul; Md Imtaiyaz Hassan
Journal:  Extremophiles       Date:  2015-11       Impact factor: 2.395

Review 6.  Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.

Authors:  Dominik Hartl; Rabindra Tirouvanziam; Julie Laval; Catherine M Greene; David Habiel; Lokesh Sharma; Ali Önder Yildirim; Charles S Dela Cruz; Cory M Hogaboam
Journal:  J Innate Immun       Date:  2018-02-13       Impact factor: 7.349

7.  Dup-24 bp in the CHIT1 Gene in Six Mexican Amerindian Populations.

Authors:  T D Da Silva-José; K J Juárez-Rendón; J A Juárez-Osuna; A Porras-Dorantes; A Valladares-Salgado; M Cruz; M Gonzalez-Ibarra; A G Soto; M T Magaña-Torres; L Sandoval-Ramírez; José Elías García-Ortiz
Journal:  JIMD Rep       Date:  2015-05-13

8.  Evaluation of Circulating Chitotriosidase Activity in Children with Obesity.

Authors:  Ioana Țaranu; Mihaela Iancu; Cecilia Lazea; Camelia Alkhzouz; Nicoleta Răcătăianu; Cristina-Sorina Cătană; Andreea-Manuela Mirea; Diana Miclea; Sorana D Bolboacă; Cristina Drugan
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

9.  Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma.

Authors:  M L Gavala; E A B Kelly; S Esnault; S Kukreja; M D Evans; P J Bertics; G L Chupp; N N Jarjour
Journal:  Clin Exp Allergy       Date:  2013-02       Impact factor: 5.018

Review 10.  The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases.

Authors:  Carole Ober; Geoffrey L Chupp
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.